Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy Authors: Giorgia Della Polla, Silvia Angelillo, Grazia Miraglia del Giudice, Italo Francesco Angelillo Published: 2026 ABSTRACT ABSTRACTLesbian, gay, bisexual, transgender, queer, intersex, asexual, and other sexually and gender-diverse populations (LGBTQIA+) are at risk for sexually transmitted infections (STIs). This survey assessed knowledge, attitudes, and vaccinations coverage for Human Papillomavirus (HPV), hepatitis A (HAV), hepatitis B (HBV), monkeypox (Mpox) and the associated determinants among 1944 LGBTQIA+ individuals in Italy. The survey was conducted between May and July 2025, through an internet-based questionnaire. Only 14.2% correctly identified HPV, HBV, HAV, and Mpox as STIs. Those younger, with university degree, in non-monogamous relationship, men who have sex with men, those with a chronic condition, with higher number of sexual partners in the last 12 months, those who were not binary, and who received information from healthcare workers (HCWs) were more knowledgeable. Only 31.7% considered all four vaccinations very useful, and this was more likely among those with university degree, in non-monogamous relationship, in homosexual, who received information from HCWs, who did not need additional information, who knew the sexual transmission of the infections, and reported condom use every time. Only 7.4% received all four vaccinations, while 39.6% received none. Younger age, having been tested for STIs, considering all vaccinations very useful, and having received information from HCWs were associated with higher uptake. Only 46.9% were willing to receive missing vaccinations. Younger age, non-monogamous relationship status, no prior testing for STIs, considering all four vaccinations very useful, higher perceived risk of being infected, having received one to three vaccinations, and needing additional information were associated with willingness. These findings highlight the role of HCWs in delivering information and prevention recommendations to improve knowledge and vaccination uptake.KEYWORDS: Behaviors, Italy, knowledge, LGBTQIA+, survey, vaccinations Background Lesbian, gay, bisexual, transgender, queer, intersex, asexual, and other sexually and gender-diverse populations (LGBTQIA+) are at elevated risk of acquiring sexually transmitted infections.1–3 In particular, the risk of Human Papillomavirus (HPV) infection is associated with receptive anal intercourse especially among men who have sex with men (MSM),4 hepatitis A virus (HAV) and hepatitis B virus (HBV) transmission have been linked, respectively, to oro-anal practices5,6 and with anal intercourse,7 and outbreaks of monkeypox (Mpox) have demonstrated clustering within sexual networks of gay, bisexual, and other MSM.8,9 It is well-known that the burden of these infections among LGBTQIA+ populations can be substantially reduced using safe and effective vaccines. In Italy, several vaccinations are currently recommended and provided free of charge for members of this community. Specifically, HPV vaccination is offered to MSM, HBV and HAV are recommended for adult MSM and individuals attending sexual health services, and Mpox vaccination is recommended for gay, bisexual, and MSM.10 Regarding the vaccination coverage, with the exception of HPV, with the highest coverage of 73.5% in females born in 2006 and of 61.3% in males born in 2008, no data is available for other adult vaccinations.11 Furthermore, it is important to note that vaccine uptake remains a critical concern among LGBTQIA+, which it is estimated to represent approximately 10% of the Italian adult population,12 with disparities in access to healthcare services and preventive interventions.13–15 To the best of our knowledge, there is a paucity of data from Italian surveys examining knowledge, attitudes, and behaviors related to some infectious diseases and their corresponding vaccinations within the LGBTQIA+ population.16–18 Consequently, it is urgent to address this gap within this community for developing and implementing appropriate and effective public healthcare policies and strategies. In this context, vaccine-related behaviors can be interpreted within a behavioral framework in which knowledge, perceived risk, perceived usefulness, and information sources interact to shape individuals’ vaccination decisions. Clarifying how these dimensions are interrelated is essential for identifying actionable determinants of vaccine uptake and informing targeted public health interventions. Therefore, the objective of this nationwide cross-sectional survey was to assess levels of knowledge, attitudes, and vaccinations coverage for HPV, HAV, HBV, and Mpox as well as to identify associated determinants among a large sample of LGBTQIA+ individuals in Italy. Understanding knowledge, attitudes, and behaviors related to vaccine-preventable diseases in this population is essential for designing effective immunization strategies. Methods Study design and participants A nationwide internet-based survey was conducted among LGBTQIA+ individuals in Italy between May and July 2025. Eligibility criteria included: (1) self-identifying as lesbian, gay, bisexual, transgender, queer, intersex, asexual, or another diverse sexual orientation or gender identity; (2) currently living in Italy; and (3) being able to read and understand Italian. The minimum required sample size was calculated assuming an estimated prevalence of 50% for vaccination against HPV, HAV, HBV, and Mpox, with a 95% confidence interval, and a margin of type I error of 0.05. Based on these assumptions, a minimum sample size of 384 participants was required. To enhance the generalizability and robustness of the findings, a substantially larger sample was recruited, resulting in a final study population of 1944 participants. Procedure Participants were recruited online through advertisements disseminated via multiple digital platforms, including social networking sites, such as Facebook, Instagram, and Twitter, dating applications, and the website of a national association involved in health promotion and prevention among LGBTQIA+ (Arcigay). Additional web-based channels were also used. Advertisements consisted of banner combining images and brief descriptive text about the survey. By clicking on the advertisement, potential participants were redirected to a secure website that provided detailed information about the survey aims, eligibility criteria, and study procedure. The website also included an informed consent form describing the voluntary nature of participation, assurances of confidentiality and anonymity, the right to withdraw at any time during the data collection process without incurring any negative consequences, and exclusive use of data for research purposes. Participants were required to indicate their consent to participate by clicking “I agree” before accessing the questionnaire. No incentives were offered for participation. The survey protocol was approved by the Ethics Committee of Campania Territoriale 2 (21819/i). Survey The questionnaire was specifically developed for the target population. It was pilot-tested with a group of 50 individuals from the same population to assess clarity, comprehensibility, and relevance. Feedback from the pilot testing was used to refine the questionnaire, but data collected during this phase were excluded from the final analysis. All questionnaire items were mandatory, and participants were allowed to review and modify their responses until final submission. The questionnaire required approximately 15 min to complete. The final questionnaire consisted of 52 closed-ended and multiple-choice items organized into six primary domains: socio-demographic and medical characteristics, sexual behaviors, knowledge, attitudes, self-reported behaviors, and sources of information. The first section collected socio-demographic and anamnestic information, including age, sex assigned at birth, gender identity, geographical area of residence, sexual orientation, marital status, employment status, educational level, and current medical conditions. It was also asked the relationship status, which included three response options: monogamous (currently in a relationship with only one sexual partner), non-monogamous (currently in a relationship with more than one sexual partner), and single (not currently in any romantic or sexual relationship). The second section assessed sexual behaviors through 12 items, asking participants whether they had ever engaged in vaginal, anal, or oral intercourse. Those who responded affirmatively to each of these questions were further asked about age at first vaginal, anal, and oral intercourse, number of sexual partners during the last 12 months, and condom use. Condom use during vaginal, anal, and oral intercourse was measured using a 5-point Likert scale, ranging from 1 “never” to 5 “always.” The third section evaluated participants’ knowledge of the transmission routes of vaccine-preventable diseases relevant to the LGBTQIA+ population (HBV, HPV, HAV, Mpox) and the vaccinations recommended for them. Participants were first asked whether they were aware of the transmission routes for vaccine-preventable diseases relevant to the LGBTQIA+ population and awareness of recommended vaccinations, with “yes” or “no” as response options. Those who responded “yes” were then allowed to select one or more applicable options from a predefined list of transmission routes and recommended vaccinations. The fourth section assessed attitudes, including perceived risk of contracting HBV, HPV, HAV, Mpox infections and perceived usefulness of the corresponding vaccinations. Attitudes were measured using a 10-point Likert-type scale, ranging from 1 indicating “not at all” to 10 indicating “very much.” The fifth section assessed self-reported vaccination status for HBV, HPV, HAV, and Mpox. Participants who reported not being vaccinated were asked about their willingness to receive the vaccine(s) and to indicate reason(s) for acceptance or refusal. The final section explored sources of information about vaccines and vaccine-preventable diseases, as well as participants’ interest in obtaining additional information. Statistical analysis Descriptive statistics were used to summarize the data. Categorical characteristics were described using frequencies, whereas continuous variables were reported as means, ranges, and standard deviations. Univariate analyses were conducted using chi-square tests for categorical variables and Student’s t-tests for continuous variables, as appropriate, to explore factors associated with the outcomes of interest. Variables with a p-value ≤ .25 in univariate analyses were considered eligible for inclusion as independent variables in multivariate models. Four models were developed to examine associations between independent variables and the following dependent variables: knowledge that HPV, HBV, HAV, and Mpox are sexually transmitted infections (no = 0; yes = 1); high perceived usefulness of HPV, HBV, HAV, and Mpox vaccinations (no = 0; yes = 1); having received HPV, HBV, HAV, and Mpox vaccinations (none = 0; one = 1; two = 2; three = 3; four = 4); and not having received all HPV, HBV, HAV, and Mpox vaccinations but intended to receive the remaining one(s) (no = 0; yes = 1). Additional analysis has been conducted to examine the determinants of uptake for each vaccine (HPV, HAV, HBV, Mpox) (Supplementary material). Multivariate logistic regression analyses were performed for knowledge, attitude, and willingness outcomes, whereas a multinomial logistic regression model was used to analyze vaccination uptake. The following potential determinants were included in the regression analyses: age, in years (continuous); gender identity (male = 1; female = 2; not binary/not conforming/questioning = 3); sexual orientation (homosexual = 1; bisexual/pansexual = 2; other = 3); marital status (unmarried/separated/divorced/widowed = 0; married/cohabitant = 1); relationship status (single = 1; monogamous = 2; non-monogamous = 3); being an MSM (no = 0; yes = 1); educational level (middle/secondary school = 0; bachelor’s/graduate degree = 1); geographical area of residence (Northern = 1; Central = 2; Southern = 3), presence of at least one chronic medical condition (no = 0; yes = 1); frequency of condom use during vaginal and anal intercourse (never/rarely/sometimes/often = 0; always = 1); number of sexual partners in the last 12 months (continuous); having received information about vaccines and vaccine-preventable diseases from healthcare workers (HCWs) (no = 0; yes = 1); and need for additional information about vaccines and vaccine-preventable diseases (no = 0; yes = 1). Knowledge that HPV, HBV, HAV, and Mpox are sexually transmitted infections (no = 0; yes = 1) and perceived risk of being infected with HPV, HBV, HAV, and Mpox (continuous) were included as independent variables in Models 2 to 4. Having been tested for sexually transmitted infections (no = 0; yes = 1), and perceived usefulness of the HPV, HBV, HAV, and Mpox vaccinations (no = 0; yes = 1) were included in Models 3 and 4. Having received the HPV, HBV, HAV, or Mpox vaccinations (none = 0; one = 1; two = 2; three = 3) was included in Model 4. The multinomial logistic regression model evaluated factors associated with having received one to four vaccinations, using the “non-vaccinated” group as the reference category. A stepwise procedure was applied with a p = .2 for entering the model and p = .4 for retention in the model. Results from multivariate logistic regression analyses are reported as odds ratios (ORs) with 95% confidence intervals (CIs), while results from the multinomial logistic regression model are presented as relative risk ratios (RRRs) with 95% CIs. Statistical significance was defined as a two-tailed p-value less or equal than .05. All analyses were conducted using STATA version 18. Results Characteristics and sexual behaviors The principal socio-demographic characteristics and sexual behaviors of the 1944 participants who met the predefined eligibility criteria are presented in Table 1. The mean age was 38.5 y, more than two-thirds assigned male at birth, two-thirds reported being unmarried/separated/divorced/widowed, more than half resided in Northern Italy, 43.9% were in a monogamous relationship, more than half identified as homosexual, less than half were graduate or above, and only 18% reported having at least one chronic medical condition. Regarding sexual behavior, those who reported ever having had sexual intercourse ranged from 51.5% for vaginal to 92% for oral sex and age at sexual debut ranged from 4 to 65 y, 81.1% having had at least one sexual partner in the last 12 months, and the condom use every time they engaged in sexual intercourse ranged from 6.4% for oral sex to 35.2% for vaginal intercourse. Table 1.Socio-demographic characteristics and sexual behaviors of the study population. N%Age, in years38.5 ± 15.5(13–89)*Sex assigned at birth Male135169.5 Female57929.8 Intersex140.7Gender identity Male135569.9 Female47524.5 Other1085.6Geographical area of residence Northern117460.4 Central36318.7 Southern40720.9Marital status Unmarried/separated/divorced/widowed134569.2 Married/cohabitant59930.8Sexual orientation Homosexual106754.9 Bisexual/Pansexual69635.8 Other1819.3Educational level Middle/Secondary school107355.2 Bachelor’s/Graduate degree87144.8Employment status Employed120962.2 Unemployed73537.8Having at least one chronic medical condition No159482 Yes35018Relationship status Monogamous85343.9 Single78940.6 Non-monogamous30215.5Having ever had vaginal sexual intercourse Yes99751.5 No93848.5Age, in years, at first vaginal intercourse18.6 ± 4.5(4–41)*Condom use during vaginal intercourse Never22822.9 Rarely10810.8 Sometimes11011 Often20020.1 Always35135.2Having ever had oral sex Yes178092 No1548Age, in years, at first oral sex18.7 ± 5.5(6–65)*Condom use during oral sex Never117766.1 Rarely21211.9 Sometimes1387.8 Often1397.8 Always1146.4Having ever had anal intercourse Yes140372.5 No53227.5Age, in years, at first anal intercourse22.4 ± 7.8(4–65)*Condom use during anal intercourse Never23516.8 Rarely1399.9 Sometimes19113.6 Often37626.8 Always46232.9Having had at least one sexual partner in the last 12 months Yes157781.1 No36718.9*Mean±standard deviation (range).Number for each item may not add up to total number of study population due to missing values. Socio-demographic characteristics and sexual behaviors of the study population. *Mean±standard deviation (range). Number for each item may not add up to total number of study population due to missing values. Knowledge regarding HBV, HPV, HAV, and Mpox and corresponding vaccinations Table 2 showed an overview on participants correct responses to questions assessing knowledge of transmission routes of vaccine-preventable diseases relevant to the LGBTQIA+ population and awareness of recommended vaccinations. With respect to transmission routes, 69.5% correctly identified sexual intercourse for HPV, whereas lower values for HBV (50.9%), HAV (35.5%), and Mpox (27.7%) (Figure 1). Overall, only 14.2% of participants correctly identified HPV, HBV, HAV, and Mpox as sexually transmitted infections. Tables 3 and 4 reported the ORs and the RRRs for respondent characteristics associated with the different outcomes of interest. Multivariate logistic regression analysis identified eight variables as independently significant predictors of knowing that HPV, HBV, HAV, and Mpox are sexually transmitted infections. Younger individuals had a higher likelihood of having correct knowledge, with a 2% decrease in odds observed for each additional year of age (OR = 0.98; 95% CI = 0.97–0.99; p < .001). Higher education was a strong predictor, with participants holding a university degree having nearly twice the odds of correct knowledge compared to those with lower education (OR = 1.99; 95% CI = 1.48–2.68; p < .001). Monogamous individuals had 42% lower odds of correct knowledge than those in non-monogamous relationship (OR = 0.58; 95% CI = 0.39–0.86; p = .007). MSM showed almost twice the odds of correct knowledge compared with other participants (OR = 1.82; 95% CI = 1.04–3.19; p = .036). Respondents having at least one chronic medical condition had 1.45 times (95% CI = 1.04–2.04; p = .031) the odds of having this knowledge compared to those with no chronic diseases. Respondents with a higher number of sexual partners in the last 12 months were also more likely to have this knowledge (OR = 1.01; 95% CI = 1.006–1.02; p < .001). Those who were not binary (OR = 0.41; 95% CI = 0.21–0.83; p = .013) compared to females and the homosexual (OR = 0.58; 95% CI = 0.38–0.89; p = .012) compared to bisexual/pansexual were also more likely to have this knowledge. Additionally, those who had received information about vaccines and vaccine-preventable diseases from HCWs were 51% (95% CI = 1.14–2.01; p = .004) more likely to correctly identify these infections as sexually transmitted compared to those who did not use this source (Model 1). When participants were asked which vaccines were recommended for them, correct responses ranged from 50.1% for Mpox to 80.5% for HPV. Overall, only 32.2% correctly identify the HPV, HBV, HAV, and Mpox vaccines as recommended. Table 2.Frequency of correct responses regarding transmission routes of vaccine-preventable diseases and their vaccinations.ItemCorrect responseN%How can HPV be transmitted?Sexual intercourse135269.5 Contact with contaminated objects25813.3How can HBV be transmitted?Sexual intercourse99050.9 Parenteral exposure101051.9How can HAV be transmitted?Sexual intercourse69135.5 Fecal-oral transmission88345.4How can Mpox be transmitted?Sexual intercourse53927.7 Contact with contaminated objects23211.9Which vaccinations are recommended for you?HPV97480.5 HBV93577.3 HAV76563.3 Mpox60650.1HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: Monkeypox. Frequency of correct responses regarding transmission routes of vaccine-preventable diseases and their vaccinations. HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: Monkeypox. Participants’ knowledge of sexual transmission, uptake, and willingness to receive HPV, HBV, HAV, and Mpox vaccinations. HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: Monkeypox. Table 3.Results of multivariate logistic regression analysis showing the factors associated with the outcomes of interest.Model 1. Knowledge that HPV, HBV, HAV, and Mpox are sexually transmitted infections Log likelihood = −661.33, χ2 = 219.58 (df = 14), p < .0001VariablesOR95% CIp valueYounger0.980.97–0.99<.001Bachelor’s/Graduate degree1.991.48–2.68<.001Having a higher number of sexual partners in the last 12 months1.011.006–1.02<.001Having received information about vaccines and vaccine-preventable diseases from HCWs1.511.14–2.01.004Relationship status Non-monogamous1* Single0.750.51–1.09.131 Monogamous0.580.39–0.86.007Sexual orientation Homosexual1* Bisexual/Pansexual0.580.38–0.89.012 Other0.450.19–1.03.061Gender identity Not binary/not conforming/questioning1* Female0.410.21–0.83.013Having at least one chronic medical condition1.451.04–2.04.031MSM1.821.04–3.19.036Geographical area of residence Northern1* Central0.730.51–1.07.109 Southern0.740.51–1.09.131No need for additional information about vaccines and vaccine-preventable diseases0.790.59–1.06.126Model 2. High perceived usefulness of HPV, HBV, HAV, and Mpox vaccinationsLog likelihood = −988.05, χ2 = 102.59 (df = 10), p < .0001Knowing that HPV, HBV, HAV, and Mpox are sexually transmitted infections2.071.55–2.77<.001Using always a condom during vaginal and anal intercourse1.611.27–2.03<.001Having received information about vaccines and vaccine-preventable diseases from HCWs1.461.17–1.82.001No need for additional information about vaccines and vaccine-preventable diseases0.690.55–0.86.001Bachelor’s/Graduate degree1.351.08–1.69.008Relationship status Non-monogamous1* Single0.760.61–0.96.021Sexual orientation Homosexual1* Bisexual/Pansexual0.710.52–0.98.038 Other0.640.38–1.06.084Not MSM0.730.53–1.02.066Having a higher number of sexual partners in the last 12 months1.0030.99–1.01.191Model 4. Not having received all HPV, HBV, HAV, and Mpox vaccinations but intended to receive the remaining one(s)Log likelihood = −932.72, χ2 = 219.54 (df = 10), p < .0001Younger0.970.96–0.98<.001High perceived usefulness of the HPV, HBV, HAV and Mpox vaccinations2.041.61–2.59<.001Need for additional information about vaccines and vaccine-preventable diseases2.281.78–2.92<.001Having received the HPV, HBV, HAV, and Mpox vaccinations None1* One1.571.17–2.11.003 Two1.431.06–1.94.021 Three2.952.08–4.19<.001Higher perceived risk of being infected with HPV, HBV, HAV, and Mpox1.111.04–1.16.001Relationship status Non-monogamous1* Monogamous0.730.58–0.91.006Not having been tested for sexually transmitted infections0.740.55–0.98.039Not MSM0.870.66–1.13.294*Reference category.HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: Monkeypox; HCWs: Healthcare workers; MSM: Men who have sex with men. Results of multivariate logistic regression analysis showing the factors associated with the outcomes of interest. *Reference category. HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: Monkeypox; HCWs: Healthcare workers; MSM: Men who have sex with men. Table 4.Results of multinomial logistic regression analysis showing the factors associated with the outcome of interest.Model 3. Having received HPV, HBV, HAV, and Mpox vaccinationsLog likelihood = −2065.11 χ2 = 742.84 (df = 72), p < .0001 One vaccinationTwo vaccinationsThree vaccinationsFour vaccinationsVariablesRRR95% CIp valueRRR95% CIp valueRRR95% CIp valueRRR95% CIp valueYounger0.970.96–0.98<.0010.950.94–0.96<.0010.930.92–0.95<.0010.930.91–0.95<.001Having been tested for sexually transmitted infections2.441.68–3.54<.0014.112.69–6.26<.0013.952.39–6.52<.0016.192.54–15.09<.001High perceived usefulness of the HPV, HBV, HAV, and Mpox vaccinations1.931.41–2.65<.0012.031.46–2.82<.0012.791.94–4.01<.0013.582.24–5.73<.001Having received information about vaccines and vaccine-preventable diseases from HCWs2.041.49–2.81<.0013.522.55–4.86<.0014.813.36–6.89<.0015.653.51–9.09<.001No need for additional information about vaccines and vaccine-preventable diseases0.710.51–0.96.0290.540.39–0.75<.0010.560.38–0.81.0020.490.31–0.79.004Bachelor’s/Graduate degree1.891.41–2.57<.0012.071.51–2.87<.0011.681.17–2.41.0051.510.94–2.41.085Knowing that HPV, HBV, HAV, and Mpox are sexually transmitted infections0.940.56–1.58.8212.011.25–3.21.0042.261.38–3.71.0014.412.53–7.64<.001Geographical area of residence Northern1* Central1.060.74–1.53.7471.090.74–1.61.6550.630.39–1.01.0520.810.45–1.44.471 Southern0.980.69–1.39.9141.850.58–1.25.4170.440.27–0.72.0010.240.11–0.53<.001Having a higher number of sexual partners in the last 12 months0.990.97–1.01.1540.990.98–1.01.9231.011.002–1.02.0131.011.002–1.02.011MSM1.060.68–1.65.7830.880.55–1.41.5951.330.77–2.32.3053.771.62–8.76.002Relationship status Non-monogamous1* 1* 1* 1* Single0.990.63–1.55.9710.910.57–1.43.6550.790.48–1.29.3431.090.61–1.95.758 Monogamous0.870.56–1.34.5270.750.48–1.18.2130.540.33–0.88.0150.240.12–0.46<.001Having at least one chronic medical condition1.110.75–1.63.6091.470.99–2.17.0541.611.04–2.48.0331.550.89–2.71.121Using always a condom during vaginal and anal intercourse0.980.72–1.35.9181.411.01–1.94.0420.890.61–1.31.5640.440.25–0.77.004Sexual orientation Homosexual1* Bisexual/Pansexual1.070.71–1.61.7351.080.69–1.67.7230.670.41–1.12.1310.840.43–1.63.607 Other0.910.49–1.69.7740.740.37–1.47.3890.480.21–1.14.0990.240.03–1.99.186Perceived risk of being infected with HPV, HBV, HAV, and Mpox1.010.93–1.08.9281.010.93–1.09.9410.990.91–1.09.9930.890.79–1.01.059*Reference category.HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: monkeypox; HCWs: Healthcare workers; MSM: Men who have sex with men. Results of multinomial logistic regression analysis showing the factors associated with the outcome of interest. *Reference category. HPV: Human papillomavirus; HBV: Hepatitis B; HAV: Hepatitis A; Mpox: monkeypox; HCWs: Healthcare workers; MSM: Men who have sex with men. Attitudes toward HBV, HPV, HAV, and Mpox and corresponding vaccinations Participants’ attitudes, measured using a 10-point Likert-type scale, showed a very low self-perceived risk of acquiring infections, since the highest level “10” was reported by only 2.6% for HAV, 2.8% for HBV, 3.1% for Mpox, and 6.4% for HPV. Overall, only 0.8% of participants perceived themselves to be at high risk for all four infections. Less than half of respondents considered the HBV, HPV, HAV, and Mpox vaccines to be “very useful” with values of 49.4%, 49%, 47.2%, and 45.5%, respectively. Overall, only 31.7% perceived all four vaccines as highly useful. Multivariate logistic regression analysis showed that individuals holding a university degree were more likely to perceive the HPV, HBV, HAV, and Mpox vaccines as useful compared with those with lower educational attainment (OR = 1.35; 95% CI = 1.08–1.69; p = .008). Being in a non-monogamous relationship was associated with more favorable views than being single (OR = 0.76; 95% CI = 0.61–0.96; p = .021). Respondents who had received information about vaccines and vaccine-preventable diseases from HCWs (OR = 1.46; 95% CI = 1.17–1.82; p = .001), those who did not express a need for additional information about vaccines and vaccine-preventable diseases (OR = 0.69; 95% CI = 0.55–0.86; p = .001), those who were homosexual (OR = 0.71; 95% CI = 0.52–0.98; p = .038) compared to bisexual/pansexual, those correctly identifying sexual transmission of the infections (OR = 2.07; 95% CI = 1.55–2.77; p < .001), and those reporting condom use every time during vaginal and anal intercourse (OR = 1.61; 95% CI = 1.27–2.03; p < .001) were more likely to have higher perceived vaccine usefulness (Model 2 in Table 3). HBV, HPV, HAV, and Mpox vaccinations uptake Self-reported vaccination uptake was very low with values of 11.6% for Mpox, 34.1% for HAV, 34.5% for HPV, and 48.2% for HBV (Figure 1). Overall, only 7.4% of participants reported having received all four vaccinations while 39.6% reported having received none. Multinomial logistic regression regarding the associated factors for individuals’ uptake of the vaccinations using non vaccination as a reference revealed multiple predictors. Younger age was consistently associated with higher vaccination uptake across all comparison groups. Having undergone testing for sexually transmitted infections and a higher perceived usefulness of the HPV, HBV, HAV, and Mpox vaccinations were also significant predictors. Respondents who had received information on the about vaccines and vaccine-preventable diseases from HCWs and those who did not report a need for additional information were more likely to have received one or more vaccinations compared to those who did not use this source and need information. Higher educational level was associated with receipt of one to three vaccinations, while correct knowledge of HPV, HBV, HAV, and Mpox sexual transmitted infections was associated with having received two to four vaccinations. Respondents having a higher number of sexual partners in the last 12 months and non-monogamous compared to monogamous relationship status were associated with higher uptake of three or four vaccinations. Participants with chronic conditions were more likely to have received three vaccinations. Finally, MSM and inconsistent condom users were more likely to have received all four vaccines while those who used it every time were more likely to have received two vaccinations (Model 3 in Table 4). HBV, HPV, HAV, and Mpox vaccinations willingness Among participants who had not received all recommended vaccinations, willingness to receive the missing one(s) was 65.7% for HBV, 62.7% for HAV, 62% for HPV, and 53.5% for Mpox, and only 46.9% expressed an intention to get the remaining ones (Figure 1). Younger age (OR = 0.97; 95% CI = 0.96–0.98; p < .001), non-monogamous relationship status compared to monogamous (OR = 0.73; 95% CI = 0.58–0.91; p = .006), no prior testing for sexually transmitted infections (OR = 0.74; 95% CI = 0.55–0.98; p = .039), having a higher perceived risk of being infected with HPV, HBV, HAV, and Mpox (OR = 1.11; 95% CI = 1.04-1.16; p = 001), perceiving HBV, HPV, HAV, and Mpox vaccines as “very useful” (OR = 2.04; 95% CI = 1.61–2.59; p < .001), having already received one (OR = 1.57; 95% CI = 1.17–2.11; p = .003), two (OR = 1.43; 95% CI = 1.06–1.94; p = .021), or three vaccinations (OR = 2.95; 95% CI = 2.08–4.19; p < .001), and expressing a desire to gain additional information about the vaccines and the diseases they prevent (OR = 2.28; 95% CI = 1.78–2.92; p < .001) were all positively associated with willingness to get the remaining vaccination(s) (Model 4 in Table 3). The most reported reasons for intending to be vaccinated were positive attitude toward vaccines (70.5% to 73.2%) and perceived vaccine safety (36.2% to 39.8%) and effectiveness (31% to 38.7%). The most endorsed reasons for unwillingness were low perceived personal risk (45.5% to 66.4%), lack of an HCW recommendation (11.2% to 20.3%), and fear of side effects (6.6% to 15.8%). Additional vaccine-specific analyses examining determinants of uptake and willingness for each vaccine (HPV, HAV, HBV, Mpox) are reported in the Supplementary Material (Table S1). Sources of information Less than two-thirds of respondents (62.7%) reported having received information about the vaccines and the diseases they prevent. The Internet was the preferential source since 70.1% of the respondents mentioned use of online websites. HCWs served as the second most common source, accounting for 58.1%. Ministry of Health and other official institutions (36.1%), LGBTQIA+ associations (31.5%), and social networks (29.3%) played relatively minor roles. Two-thirds of respondents (67.2%) expressed interest in receiving additional information. Discussion This national survey assessing knowledge, risk perception, behaviors, and associated factors related to vaccine-preventable diseases among a large sample of LGBTQIA+ individuals in Italy yielded several valuable findings. These results can be interpreted within a behavioral framework in which knowledge, perceived risk, perceived usefulness of vaccination, and exposure to different sources of information jointly influence vaccination uptake and willingness. The results suggest that these factors do not operate independently but interact synergistically to shape vaccination-related decision-making processes. The level of knowledge regarding HPV, HBV, HAV, and Mpox infections was unexpectedly low. Only 14.2% of participants correctly identified all infections as sexually transmitted. This level of knowledge was considerably lower than that reported in a survey conducted in Belgium, where 73.3% of MSM correctly identified HBV as a sexually transmitted infection.19 Knowledge was shown to have a significant impact on vaccine attitude and uptake, as participants who correctly recognized the sexual transmission of these infections were more likely to perceive the vaccinations useful and to have received at least two vaccinations. Similar associations have been reported in previous studies, showing that individuals with higher levels of knowledge about infectious diseases and their vaccines were more likely to be vaccinated.20–22 These findings suggest that improving knowledge may have an important role into positively shaping attitudes toward vaccination and indicate a need for targeted public health initiatives, particularly sexual health educational interventions, to address existing knowledge gaps, in order to effectively manage the risk of acquiring these infections and to increase vaccine uptake within this population. A very low self-perceived risk of acquiring HAV, HBV, Mpox, and HPV infections has been observed. The proportion of participants who perceived themselves at high risk ranged from 2.6% for HAV to 6.4% for HPV and, overall, only 0.8% have this perception for all four infections. Moreover, less than half of respondents considered the corresponding vaccinations to be “very useful,” with values ranging from 45.5% for Mpox to 49.4% for HBV and, overall, less than one-third considered all four vaccinations “very useful.” The multivariate analysis showed that relationship status and condom use were also significant predictors of this positive attitude, with individuals in non-monogamous relationships and those using condoms every time during vaginal and anal intercourse reporting a higher perceived usefulness of these vaccinations. The association between consistent condom use and positive attitude toward vaccination may reflect a broader preventive health orientation, whereby individuals who routinely engage in protective sexual behaviors may be more likely to recognize and value additional prevention strategies. Consistent condom use may indicate higher health literacy and, as previously reported, greater awareness of sexually transmitted infection risk, factors that are known to influence favorable attitudes toward vaccination. Furthermore, the more positive attitude observed among individuals in non-monogamous relationships may be attributable to a heightened perception of personal health risk facilitating more favorable evaluations of vaccination. Vaccination uptake was concerningly low with values of 11.6% for Mpox, 34.1% for HAV, 34.5% for HPV, and 48.2% for HBV. Only 7.4% of participants reported having received all four vaccinations, while 39.6% reported receiving none. Similar low Mpox vaccination coverage with one or two doses has been reported among gay, bisexual, and MSM populations with values of 12.6% and 4.4% in New Zealand,23 7.7% and 13.9% in Hong Kong,24 13% and 44% in Taiwan,25 and among gay, bisexual men, and non-binary people who had not been diagnosed with Mpox with values of 12.3% and 41.5% in Australia.26 HPV vaccination uptake in this survey was higher than those observed among MSM in France (15%),27 United States (17.9%),28 China (23%),29 and Australia (24.1%).30 Lastly, uptake was substantially lower than coverage among gay, bisexual, and other MSM for Mpox (69%), HAV (68%), HBV (72%), and HPV (65%) in the UK,31 for HAV (60%) in the United States,32 for HAV (51%) and HBV (57%) in Ireland,33 and among MSM for HAV (48%) and HBV (58%) across the WHO European Region.34 Despite low coverage, willingness to receive missing vaccinations was relatively high among unvaccinated or partially vaccinated respondents, ranging from 53.5% for Mpox to 65.7% for HBV and only 46.9% expressed intention to receive all remaining vaccines. A significant lower willingness was observed with increasing age, whereas younger participants showed greater propensity to be vaccinated. This pattern is consistent with previous public health investigations indicating that those younger are more engaged in preventive health behaviors35–38 and this may reflect greater exposure to health education and preventive messaging, making them more receptive to health seeking behavior including vaccination. While composite outcomes provide a comprehensive overview, the vaccine-specific analyses highlight that determinants of uptake and willingness may vary across infections, suggesting the need for tailored strategies targeting each vaccine. Perceptions of vaccine safety and effectiveness emerged as the most prevalent cited reasons among unvaccinated participants to accept vaccination in the future. Conversely, the most endorsed reasons for negative attitudes included not feel to be at risk, lack a recommendation from an HCW, and fear of vaccines’ side effects. A concerning finding was the absence of HCW recommendations, as a large body of literature from different countries have clearly demonstrated that HCWs’ recommendation is a key driver of participation in health checkups that influence willingness or vaccine uptake.39–41 Consequently, these findings underscore the urgent need for health policymakers to strengthen public health strategies and improve communication between HCWs and LGBTQIA+ individuals. Most participants reported obtaining information about vaccine-preventable infections from various sources, primarily Internet and HCWs. However, of concern is the finding that more than two-thirds had used Internet, the most easily and quickly accessible source, as previous research has shown that misinformation disseminated online can negatively influence perceptions of vaccination and related decision-making.42–44 In contrast, information provided by HCWs was a strong predictor of higher participants’ knowledge and vaccination coverage. Indeed, respondents who received information from HCWs and those who reported no need for additional information were significantly more likely to have received at least one vaccination compared with those who did not rely on this source and expressed unmet information needs. This consistent association highlights the crucial influence that information sources may play on vaccination decisions. This is in line with findings from other studies across diverse populations.45–47 Logistic regression analyses offered further insight into factors influencing the vaccine-related knowledge, attitudes, and uptake. Participants with a bachelor’s degree or higher were more likely to demonstrate better knowledge, more positive attitudes, and a higher likelihood of vaccination, although not against all four diseases, compared to those with lower level of education. This finding aligns with previous evidence suggesting that higher education may facilitate access to and comprehension of health-related information.48,49 Those reporting a higher number of sexual partners in the last 12 months and those in non-monogamous relationships were more likely to have received three or four vaccinations. Moreover, being MSM and not using condoms every time in vaginal and anal intercourse were associated with having received all four vaccinations. These findings suggest a degree of health consciousness within these communities, whereby greater awareness of sexual health risks and engagement in higher-risk behaviors may encourage preventive activities to protect both themselves and their partner, including vaccination. Younger age, having undergone sexually transmitted infections testing, and holding positive attitudes toward vaccination, were also associated with higher vaccine uptake. The identification of the multiple factors associated with the outcomes of interest clearly indicates the need for tailored and personalized vaccination strategies for this population. Lastly, the perceived lack of usefulness of HPV, HBV, HAV, and Mpox vaccines emerged as one of the most prominent determinants of non-vaccination. This finding highlights a persistent gap between the available scientific evidence supporting these vaccines and public understanding of their benefits, underscoring the urgent need for targeted, up-to-date, and evidence-based communication strategies to address misconceptions and strengthen confidence, which could improve adherence to vaccination programs. While this nationwide survey offers valuable insights into vaccination-related knowledge, attitudes, and coverage and the related determinants among LGBTQIA+ individuals in Italy, potential methodological limitations should be considered. First, the cross-sectional design precludes causal inference between the outcomes and the characteristics since both were measured at the same time, and reverse causality cannot be excluded as the temporal relationship cannot be established. Second, the use of a convenience sample is critical because it may affect the representativeness of the target population, namely the broader LGBTQIA+ population in Italy. Third, the Internet-based survey design may have underrepresented individuals with limited Internet access or lower digital literacy and it may arise doubts about the validity and authenticity of the information. However, appropriate methodological steps have been implemented since the survey was distributed through controlled and targeted channels to reach a defined population and attention checks and internal consistency measures were incorporated to identify and exclude inattentive or invalid responses. Fourth, reliance on self-reported data may have introduced recall bias (e.g. vaccination status) that is related to the potential differential misclassification of the exposure, having knowledge of the outcome, and vice versa. This misclassification may have affected the estimated associations, resulting in an over- or an underestimation of the effects. Moreover, social desirability bias for sensitive questions (e.g. sexual practices) may have led to under- or overreported of some behaviors. However, confidentiality and anonymity were emphasized to encourage honest responses and may have mitigated these biases. Fifth, the lack of information on participants’ migration background may have led to an incomplete assessment of potential inequalities in access to preventive services and vaccination behaviors. This is particularly relevant for migrant populations, who often face additional structural, linguistic, and socio-economic barriers to healthcare access and utilization. Despite these potential limitations, the data provide a valuable foundation for the development of targeted vaccination campaigns and educational programs tailored to the LGBTQIA+ community. Conclusions In conclusion, the survey findings provide strong guidance for future public health activities and educational initiatives. A salient message is the critical role of HCWs in delivering targeted information and prevention recommendations to address gaps in knowledge and vaccination uptake. Strengthening HCW engagement with this population is essential for improving vaccine coverage and, ultimately, health outcomes among LGBTQIA+ individuals in Italy. Supplementary Material Supplementary material.docx Acknowledgments The authors deeply appreciate the time and effort of all the participants who take part in the survey and the association Arcigay for their contribution in publicizing the survey. Biography Italo Francesco Angelillo is a Full Professor of Hygiene at the Medical School of the University of Campania “Luigi Vanvitelli,” Italy. At the Harvard University (Boston, MA, USA), he was a Visiting Scholar at the School of Public Health in the Department of Health Policy and Management and at the School of Dental Medicine in the Department of Dental Care Administration, and he has also received an MPH at the School of Public Health. He is Director of the Unit of Hospital Hygiene and of the Department of Public Health and Laboratory Services in the Teaching University Hospital and Vice Rector of the University of Campania “Luigi Vanvitelli.” The research activity focused on the level of knowledge of infectious diseases and of the main preventive measures, the attitudes regarding the risk of acquiring infectious diseases, and the behavior toward preventive measures among at-risk groups of population. Funding Statement The work was supported by the Italian Ministry of University and Research (MUR) under the Italian Piano Nazionale di Ripresa e Resilienza (PNRR), Grant [BEHAVE-MOD] [ID: COC-1-2023-ISS-02 INF-Act], and by the Italian Medicines Agency (AIFA), Pharmacovigilance funding 2015–2017 [ID: GeFF: 20240200000001381]. Disclosure statement No potential conflict of interest was reported by the author(s). Data availability statement The data underlying this article will be shared on reasonable request to the corresponding author. Ethics approval and consent to participate Approval of the study protocol and instrument was given by the Ethics Committee Campania Territoriale 2 (21819/i) and data collection was performed according to the Declaration of Helsinki ethical principles. Informed consent to participate in the survey was implied by participants’ electronic agreement prior to accessing and completing the questionnaire. Supplemental material Supplemental data for this article can be accessed online at https://doi.org/10.1080/21645515.2026.2692302 References Associated Data Supplementary Materials Supplementary material.docx Data Availability Statement The data underlying this article will be shared on reasonable request to the corresponding author.